IL163805A0 - Indazoles substituted with an anti-cancerous activity - Google Patents

Indazoles substituted with an anti-cancerous activity

Info

Publication number
IL163805A0
IL163805A0 IL16380503A IL16380503A IL163805A0 IL 163805 A0 IL163805 A0 IL 163805A0 IL 16380503 A IL16380503 A IL 16380503A IL 16380503 A IL16380503 A IL 16380503A IL 163805 A0 IL163805 A0 IL 163805A0
Authority
IL
Israel
Prior art keywords
cancerous activity
indazoles substituted
indazoles
substituted
cancerous
Prior art date
Application number
IL16380503A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL163805A0 publication Critical patent/IL163805A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cosmetics (AREA)
IL16380503A 2002-03-11 2003-03-07 Indazoles substituted with an anti-cancerous activity IL163805A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0202996A FR2836914B1 (fr) 2002-03-11 2002-03-11 Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
PCT/FR2003/000751 WO2003078402A1 (fr) 2002-03-11 2003-03-07 Indazoles substitues avec une activite anticancereuse

Publications (1)

Publication Number Publication Date
IL163805A0 true IL163805A0 (en) 2005-12-18

Family

ID=27763684

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16380503A IL163805A0 (en) 2002-03-11 2003-03-07 Indazoles substituted with an anti-cancerous activity
IL163805A IL163805A (en) 2002-03-11 2004-08-30 Transformed islands with anti-cancer activity

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL163805A IL163805A (en) 2002-03-11 2004-08-30 Transformed islands with anti-cancer activity

Country Status (29)

Country Link
US (2) US6858638B2 (pl)
EP (1) EP1487803A1 (pl)
JP (1) JP4643910B2 (pl)
KR (1) KR20040091128A (pl)
CN (1) CN100369899C (pl)
AR (1) AR038914A1 (pl)
AU (1) AU2003242808B2 (pl)
BR (1) BR0308339A (pl)
CA (1) CA2478540A1 (pl)
EC (1) ECSP045286A (pl)
FR (1) FR2836914B1 (pl)
GT (1) GT200300031A (pl)
HN (1) HN2003000094A (pl)
HR (1) HRP20040825A2 (pl)
IL (2) IL163805A0 (pl)
MA (1) MA27176A1 (pl)
MX (1) MXPA04008446A (pl)
NO (1) NO20044261L (pl)
OA (1) OA12784A (pl)
PA (1) PA8566701A1 (pl)
PE (1) PE20040071A1 (pl)
PL (1) PL372389A1 (pl)
RU (1) RU2004130280A (pl)
SV (1) SV2003001493A (pl)
TN (1) TNSN04175A1 (pl)
TW (1) TW200303863A (pl)
UY (1) UY27712A1 (pl)
WO (1) WO2003078402A1 (pl)
ZA (1) ZA200406730B (pl)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2836914B1 (fr) * 2002-03-11 2008-03-14 Aventis Pharma Sa Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
GB0218625D0 (en) * 2002-08-10 2002-09-18 Astex Technology Ltd Pharmaceutical compounds
WO2004037814A1 (en) * 2002-10-25 2004-05-06 Vertex Pharmaceuticals Incorporated Indazolinone compositions useful as kinase inhibitors
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
WO2005014554A1 (en) * 2003-08-08 2005-02-17 Astex Therapeutics Limited 1h-indazole-3-carboxamide compounds as mapkap kinase modulators
FR2864084B1 (fr) * 2003-12-17 2006-02-10 Aventis Pharma Sa Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
EP1694686A1 (en) * 2003-12-19 2006-08-30 Takeda San Diego, Inc. Kinase inhibitors
GB0330042D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
GB0330043D0 (en) * 2003-12-24 2004-01-28 Pharmacia Italia Spa Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
EP1763524A1 (en) * 2004-04-23 2007-03-21 Takeda San Diego, Inc. Indole derivatives and use thereof as kinase inhibitors
US7550598B2 (en) * 2004-08-18 2009-06-23 Takeda Pharmaceutical Company Limited Kinase inhibitors
JP4682207B2 (ja) * 2004-09-29 2011-05-11 エフ．ホフマン−ラ ロシュ アーゲー １１ｂ−ｈｓｄ１阻害剤としてのインドゾロン誘導体
US7713973B2 (en) 2004-10-15 2010-05-11 Takeda Pharmaceutical Company Limited Kinase inhibitors
SE0402763D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Nitro indazole derivatives
SE0402762D0 (sv) * 2004-11-11 2004-11-11 Astrazeneca Ab Indazole sulphonamide derivatives
EP1919877A1 (en) * 2005-08-25 2008-05-14 F.Hoffmann-La Roche Ag P38 map kinase inhibitors and methods for using the same
US8119655B2 (en) 2005-10-07 2012-02-21 Takeda Pharmaceutical Company Limited Kinase inhibitors
CN101415685B (zh) 2006-01-31 2011-08-24 阿雷生物药品公司 激酶抑制剂及其使用方法
SG175609A1 (en) 2006-10-09 2011-11-28 Takeda Pharmaceutical Kinase inhibitors
EP2223925A1 (en) * 2006-10-09 2010-09-01 Takeda Pharmaceutical Company Limited Kinase inhibitors
WO2008063888A2 (en) * 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
FR2917735B1 (fr) * 2007-06-21 2009-09-04 Sanofi Aventis Sa Nouveaux indazoles substitutes, leur preparation et leur utilisation en therapeutique
CN101754955A (zh) 2007-07-16 2010-06-23 雅培制药有限公司 作为蛋白激酶抑制剂的吲唑、苯并异*唑和苯并异噻唑化合物
US20220315555A1 (en) 2009-05-26 2022-10-06 Abbvie Inc. Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
US9034875B2 (en) 2009-05-26 2015-05-19 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US8546399B2 (en) 2009-05-26 2013-10-01 Abbvie Inc. Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
HUE027698T2 (en) * 2009-05-26 2016-10-28 Abbvie Bahamas Ltd Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases
WO2011050245A1 (en) * 2009-10-23 2011-04-28 Yangbo Feng Bicyclic heteroaryls as kinase inhibitors
CN102247361B (zh) * 2010-05-20 2015-04-29 中国医学科学院药物研究所 5-硝基-1氢-吲唑-3-腈在制备药物中的应用
UA113500C2 (xx) 2010-10-29 2017-02-10 Одержані екструзією розплаву тверді дисперсії, що містять індукуючий апоптоз засіб
CA3152557A1 (en) 2010-10-29 2012-05-03 Abbvie Inc. Solid dispersions containing an apoptosis-inducing agent
MY191300A (en) 2010-11-23 2022-06-14 Abbvie Ireland Unlimited Co Methods of treatment using selective bcl-2 inhibitors
JP6141188B2 (ja) 2010-11-23 2017-06-07 アッヴィ・インコーポレイテッド アポトーシス誘導剤の塩および結晶の形態
US20140275082A1 (en) 2013-03-14 2014-09-18 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
AU2015341913B2 (en) * 2014-11-03 2020-07-16 Iomet Pharma Ltd Pharmaceutical compound
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy
JP2020528415A (ja) 2017-07-21 2020-09-24 カドモン コーポレイション，リミティド ライアビリティ カンパニー Ｒｈｏ関連コイルドコイル含有プロテインキナーゼの阻害剤
US11186549B2 (en) 2017-08-29 2021-11-30 Rutgers, The State University Of New Jersey Therapeutic indazoles
CN118715205A (zh) * 2022-01-12 2024-09-27 艾福姆德尤股份有限公司 用于治疗与sting活性相关的病症的化合物和组合物
CN114605329B (zh) * 2022-03-28 2024-01-26 河南中医药大学 取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途
WO2024145569A2 (en) 2022-12-30 2024-07-04 Avicenna Biosciences, Inc. Azaindole rock inhibitors

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS514505Y2 (pl) 1971-02-13 1976-02-07
JPH061350B2 (ja) * 1985-07-26 1994-01-05 コニカ株式会社 ハロゲン化銀写真感光材料
EA001367B1 (ru) 1996-02-22 2001-02-26 Туларик, Инк. Пентафторбензолсульфонамиды и их аналоги
EP0939627B1 (en) * 1996-07-19 2003-09-10 Tularik, Inc. Pentafluorobenzenesulfonamides and analogs
GB9718913D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase
WO2000027627A1 (en) 1998-11-12 2000-05-18 Eli Lilly And Company Aryloxime linkers in the solid-phase synthesis of 3-aminobenzisoxazoles
CO5170498A1 (es) * 1999-05-28 2002-06-27 Abbott Lab Biaril sulfonamidas son utiles como inhibidores de proliferacion celular
YU54202A (sh) 2000-01-18 2006-01-16 Agouron Pharmaceuticals Inc. Jedinjenja indazola, farmaceutske smeše i postupci za stimulisanje i inhibiranje ćelijske proliferacije
KR100423899B1 (ko) * 2000-05-10 2004-03-24 주식회사 엘지생명과학 세포 증식 억제제로 유용한 1,1-디옥소이소티아졸리딘을갖는 인다졸
US6897231B2 (en) * 2000-07-31 2005-05-24 Signal Pharmaceuticals, Inc. Indazole derivatives as JNK inhibitors and compositions and methods related thereto
CN1300116C (zh) * 2001-04-16 2007-02-14 卫材株式会社 1h－吲唑化合物
US7199147B2 (en) 2001-06-12 2007-04-03 Dainippon Sumitomo Pharma Co., Ltd. Rho kinase inhibitors
EP1401831A1 (en) * 2001-07-03 2004-03-31 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
US7101884B2 (en) 2001-09-14 2006-09-05 Merck & Co., Inc. Tyrosine kinase inhibitors
FR2836915B1 (fr) 2002-03-11 2008-01-11 Aventis Pharma Sa Derives d'aminoindazoles, procede de preparation et intermediaires de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
FR2836914B1 (fr) * 2002-03-11 2008-03-14 Aventis Pharma Sa Indazoles substitues, compositions les contenant, procede de fabrication et utilisation

Also Published As

Publication number Publication date
MA27176A1 (fr) 2005-01-03
FR2836914B1 (fr) 2008-03-14
HRP20040825A2 (en) 2005-06-30
WO2003078402A1 (fr) 2003-09-25
US20040106667A1 (en) 2004-06-03
MXPA04008446A (es) 2004-12-06
FR2836914A1 (fr) 2003-09-12
KR20040091128A (ko) 2004-10-27
HN2003000094A (es) 2003-12-15
PA8566701A1 (es) 2003-12-10
ECSP045286A (es) 2004-10-26
RU2004130280A (ru) 2005-06-27
TNSN04175A1 (fr) 2007-03-12
CN100369899C (zh) 2008-02-20
TW200303863A (en) 2003-09-16
PE20040071A1 (es) 2004-02-13
CN1642922A (zh) 2005-07-20
US7473701B2 (en) 2009-01-06
UY27712A1 (es) 2003-09-30
GT200300031A (es) 2006-05-26
AU2003242808B2 (en) 2008-09-18
JP2005533004A (ja) 2005-11-04
CA2478540A1 (fr) 2003-09-25
EP1487803A1 (fr) 2004-12-22
PL372389A1 (pl) 2005-07-25
IL163805A (en) 2009-08-03
US6858638B2 (en) 2005-02-22
AR038914A1 (es) 2005-02-02
US20050059722A1 (en) 2005-03-17
OA12784A (fr) 2006-07-10
AU2003242808A1 (en) 2003-09-29
NO20044261L (no) 2004-11-25
SV2003001493A (es) 2003-07-10
JP4643910B2 (ja) 2011-03-02
ZA200406730B (en) 2005-08-24
BR0308339A (pt) 2005-02-01

Similar Documents

Publication Publication Date Title
IL163805A0 (en) Indazoles substituted with an anti-cancerous activity
GB2394991B (en) Mounting arrangement
GB0605908D0 (en) Connection arrangement
GB0214383D0 (en) Catalyst
AU155291S (en) An earphone
AU2003238868A8 (en) Software atomization
GB2391023B (en) An intumescent assembly
AU152403S (en) Faceshield attachment
GB2387804B (en) Component structure
GB0215492D0 (en) Mounting arrangement
GB0216702D0 (en) Webbing arrangement
TW547546U (en) Axis structure
GB0212963D0 (en) Uni-rod rest
GB0221126D0 (en) Pollymer converter
AU2002249931A8 (en) An airwing structure
TW575159U (en) Diversion structure
GB0226927D0 (en) An attachment
GB0205195D0 (en) Concept seven
PL354789A1 (pl) Centrum montażoweCentrum montażowe
HU2506U (en) Distance-piece- fastener structure
GB0220924D0 (en) Structure
GB0220926D0 (en) Structure
TW539129U (en) Micro-pitch connection structure
GB0210565D0 (en) Concept three
GB0213077D0 (en) Concept nine